
### [NCIT:C9333](http://purl.obolibrary.org/obo/NCIT_C9333)
**Label:** Malignant Appendix Neoplasm

**Subclasses:** [NCIT:C134118](http://purl.obolibrary.org/obo/NCIT_C134118) (Stage 0 Appendix Carcinoma AJCC v8), [NCIT:C134117](http://purl.obolibrary.org/obo/NCIT_C134117) (Appendix Carcinoma by AJCC v8 Stage), [NCIT:C3689](http://purl.obolibrary.org/obo/NCIT_C3689) (Appendix Goblet Cell Carcinoid), [NCIT:C96434](http://purl.obolibrary.org/obo/NCIT_C96434) (Appendix Kaposi Sarcoma), [NCIT:C4593](http://purl.obolibrary.org/obo/NCIT_C4593) (Stage 0 Appendix Carcinoma AJCC v7), [NCIT:C43564](http://purl.obolibrary.org/obo/NCIT_C43564) (Appendix Mixed Adenoneuroendocrine Carcinoma), [NCIT:C87798](http://purl.obolibrary.org/obo/NCIT_C87798) (Stage I Appendix Carcinoma AJCC v7), [NCIT:C96435](http://purl.obolibrary.org/obo/NCIT_C96435) (Appendix Leiomyosarcoma), [NCIT:C134119](http://purl.obolibrary.org/obo/NCIT_C134119) (Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8), [NCIT:C134125](http://purl.obolibrary.org/obo/NCIT_C134125) (Stage III Appendix Carcinoma AJCC v8), [NCIT:C134129](http://purl.obolibrary.org/obo/NCIT_C134129) (Stage IV Appendix Carcinoma AJCC v8), [NCIT:C5511](http://purl.obolibrary.org/obo/NCIT_C5511) (Appendix Mucinous Cystadenocarcinoma), [NCIT:C133733](http://purl.obolibrary.org/obo/NCIT_C133733) (Appendix Carcinoma by AJCC v7 Stage), [NCIT:C96421](http://purl.obolibrary.org/obo/NCIT_C96421) (High Grade Appendix Mucinous Adenocarcinoma), [NCIT:C5513](http://purl.obolibrary.org/obo/NCIT_C5513) (Appendix Lymphoma), [NCIT:C43554](http://purl.obolibrary.org/obo/NCIT_C43554) (Appendix Signet Ring Cell Carcinoma), [NCIT:C134121](http://purl.obolibrary.org/obo/NCIT_C134121) (Stage II Appendix Carcinoma AJCC v8), [NCIT:C43555](http://purl.obolibrary.org/obo/NCIT_C43555) (Appendix Small Cell Neuroendocrine Carcinoma), [NCIT:C134120](http://purl.obolibrary.org/obo/NCIT_C134120) (Stage I Appendix Carcinoma AJCC v8), [NCIT:C9330](http://purl.obolibrary.org/obo/NCIT_C9330) (Appendix Carcinoma), [NCIT:C43556](http://purl.obolibrary.org/obo/NCIT_C43556) (Appendix Undifferentiated Carcinoma), [NCIT:C43558](http://purl.obolibrary.org/obo/NCIT_C43558) (Appendix Mucinous Adenocarcinoma), [NCIT:C42598](http://purl.obolibrary.org/obo/NCIT_C42598) (Low-Grade Appendiceal Mucinous Neoplasm), [NCIT:C96425](http://purl.obolibrary.org/obo/NCIT_C96425) (Appendix Neuroendocrine Carcinoma), [NCIT:C96426](http://purl.obolibrary.org/obo/NCIT_C96426) (Appendix Large Cell Neuroendocrine Carcinoma), [NCIT:C7718](http://purl.obolibrary.org/obo/NCIT_C7718) (Appendix Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0001154](http://purl.obolibrary.org/obo/UBERON_0001154) (vermiform appendix) 66.67%
- [NCIT:C36122](http://purl.obolibrary.org/obo/NCIT_C36122) (Benign Cellular Infiltrate) 66.67%
- Thing 51.39%
- [NCIT:C42077](http://purl.obolibrary.org/obo/NCIT_C42077) (Cellular Infiltrate) 28.45%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 19.91%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 19.25%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 19.15%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 19.15%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 19.03%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 18.46%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 18.28%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 18.19%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 18.19%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 18.18%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 18.09%


